Altium Capital Management LP Portfolio Holdings

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Altium Capital Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $283 Million distributed in 79 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vera Therapeutics, Inc. with a value of $30.2M, Adma Biologics, Inc. with a value of $27.2M, Sarepta Therapeutics, Inc. with a value of $21.2M, Edwards Lifesciences Corp with a value of $14.6M, and Xenon Pharmaceuticals Inc. with a value of $14.2M.

Examining the 13F form we can see an increase of $95.7M in the current position value, from $188M to 283M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $283 Million
Healthcare: $278 Million
Consumer Cyclical: $3.99 Million
Industrials: $102,000
Financial Services: $2,000

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 79
  • Current Value $283 Million
  • Prior Value $188 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 31 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email